National Covid-19 Surveillance Physicians

National Covid-Surveillance Physicians

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04459312

Acronym

NAT-COV-SURV

Enrollment

600

Registered

2020-07-07

Start date

2020-06-01

Completion date

2020-09-30

Last updated

2020-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antibody COVID-19

Brief summary

The investigators will analyze the presence of antibodies against SARS-COV2 in physicians working in emergency and intensive care medicine and in those who treat Covid 19 patients.

Interventions

DIAGNOSTIC_TESTAntibody test (SARS-CoV2)

Antibody test

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 99 Years

Healthy volunteers

Yes

Inclusion criteria

* Qualified as physician

Exclusion criteria

* none

Design outcomes

Primary

Measure	Time frame
Presence of antibodies against SARS-COV2	3 months

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026